Related Experiment Videos
Sensitivity and interobserver variability of the Recombigen-HIV-1 LA test
J A Houck1, D D Sedmak, M P Grose
1Department of Pathology, Ohio State University, Columbus.
American Journal of Clinical Pathology
|April 1, 1990
Summary
The Recombigen-HIV-1 LA Test shows 92% sensitivity for detecting HIV-1 antibodies, but interpretation challenges and lower accuracy compared to other methods limit its use as a primary screening tool.
Area of Science:
- Medical Diagnostics
- Virology
- Immunology
Background:
- The Recombigen-HIV-1 LA Test is a latex agglutination assay for detecting human immunodeficiency virus type 1 (HIV-1) antibodies.
- It is intended for screening in settings lacking enzyme immunoassays.
- Concerns exist regarding its sensitivity, specificity, and interpretation difficulty.
Purpose of the Study:
- To evaluate the sensitivity and interobserver variability of the Recombigen-HIV-1 LA Test.
- To compare its performance in a hospital laboratory setting.
Main Methods:
- A blinded study assessed the latex agglutination assay using sera from confirmed HIV-1 positive patients.
- A second study involved three technologists evaluating samples with varying EIA/WB results.
- Sensitivity was determined by comparing results to enzyme immunoassay (EIA) and western blot (WB).
Main Results:
- The assay demonstrated 92% sensitivity in detecting HIV-1 antibodies.
- Interobserver variability was observed in 20% of interpretations, indicating challenges with weak agglutination.
- Agreement among technologists was 80% for all samples.
Conclusions:
- The Recombigen-HIV-1 LA Test's sensitivity is lower than EIA or WB techniques.
- Interobserver variation in interpreting agglutination patterns impacts its reliability.
- Its limitations may restrict its utility as a sole screening test for HIV-1.